研究单位：[1]Chinese PLA General Hospital[2]Beijing Chao Yang Hospital[3]Ministry of Health, China[4]Peking University Third Hospital[5]Tianjin Medical University General Hospital[6]First Hospital of China Medical University[7]Shengjing Hospital[8]Second Hospital of Jilin University[9]Shandong Provincial Hospital[10]Huadong Hospital[11]Nanjing PLA General Hospital[12]Fuzhou General Hospital[13]Guangzhou Institute of Respiratory Disease[14]Wuhan TongJi Hospital[15]Health Science Center of Xi'an Jiaotong University[16]Guizhou Provincial People's Hospital[17]Shenyang Military General Hospital[18]The Second Hospital of Hebei Medical University[19]Xiangya Hospital of Central South University[20]Fujian Provincial Hospital[21]Fuzhou Pulmonary Hospital of Fujian[22]Southwest Hospital, China[23]First Affiliated Hospital of Zhejiang University[24]Wenzhou Medical University[25]Shanghai Zhongshan Hospital[26]The First Affiliated Hospital of Nanchang University[27]Longyan City First Hospital
The purpose of the study:1.Improve the understanding of the risk factors of pulmonary cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in different conditions;4.Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.
